[Anabolic and catabolic action of PTH].
Ishizuya
Toshinori
T
First Laboratory for Pharmacology, Asahi Kasei Pharma Co. Ltd.
D000818:Animals; D001862:Bone Resorption; D001842:Bone and Bones / Q000378:metabolism*; D015536:Down-Regulation; D054769:G-Protein-Coupled Receptor Kinase 2; D006801:Humans; D010006:Osteoblasts / Q000502:physiology; D010012:Osteogenesis / Q000187:drug effects; D010281:Parathyroid Hormone / Q000008:administration & dosage* / Q000097:blood / Q000494:pharmacology*; D044168:Receptor, Parathyroid Hormone, Type 1; D018016:Receptors, Parathyroid Hormone / Q000502:physiology; D051552:beta-Adrenergic Receptor Kinases / Q000502:physiology
C473449:PTH1R protein, human; D010281:Parathyroid Hormone; D044168:Receptor, Parathyroid Hormone, Type 1; D018016:Receptors, Parathyroid Hormone; C496569:Grk2 protein, rat; D051552:beta-Adrenergic Receptor Kinases; D054769:G-Protein-Coupled Receptor Kinase 2